Performance of O-RADS MRI Score for Classifying Indeterminate Adnexal Masses at US.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Diagnostic reliability of O-RADS score based on non-dynamic contrast-enhanced MRI and apparent diffusion coefficient in characterization of adnexal masses.BMC medical imaging · 2026
   Article
2. Navigating Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging (O-RADS MRI): A Review of Its Evolution, Current Advances, and Persistent Challenges in Ovarian Imaging.Cureus · 2025
   Review
3. Diagnostic value of magnetic resonance imaging for malignant ovarian tumors mis-subclassified by the ultrasound-based ADNEX model.Frontiers in oncology · 2025
   Article
4. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2023
   Article
5. American college of radiology ovarian-adnexal reporting and data system ultrasound (O-RADS): Diagnostic performance and inter-reviewer agreement for ovarian masses in children.Frontiers in pediatrics · 2023
   Article
6. A comparison of the diagnostic performance of the O-RADS, RMI4, IOTA LR2, and IOTA SR systems by senior and junior doctors.Ultrasonography (Seoul, Korea) · 2022
   Article
7. Diffusion-Weighted MRI in the Genitourinary System.Journal of clinical medicine · 2022
   Review
8. Machine-learning-based contrast-enhanced computed tomography radiomic analysis for categorization of ovarian tumors.Frontiers in oncology · 2022
   Article
9. O-RADS: the evolution of the ovarian lesion classification system.Radiologia brasileira
   Article

Corrections and comments

• Comment on
  Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as